JP6383141B2 - Surface-treated powder and skin external preparation containing the surface-treated powder - Google Patents
Surface-treated powder and skin external preparation containing the surface-treated powder Download PDFInfo
- Publication number
- JP6383141B2 JP6383141B2 JP2013178815A JP2013178815A JP6383141B2 JP 6383141 B2 JP6383141 B2 JP 6383141B2 JP 2013178815 A JP2013178815 A JP 2013178815A JP 2013178815 A JP2013178815 A JP 2013178815A JP 6383141 B2 JP6383141 B2 JP 6383141B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- external preparation
- phenyl group
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims description 57
- 238000002360 preparation method Methods 0.000 title claims description 36
- 229920001296 polysiloxane Polymers 0.000 claims description 65
- 239000000049 pigment Substances 0.000 claims description 55
- 239000002537 cosmetic Substances 0.000 claims description 36
- 125000004432 carbon atom Chemical group C* 0.000 claims description 31
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 27
- 239000004606 Fillers/Extenders Substances 0.000 claims description 17
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 239000011164 primary particle Substances 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 238000006116 polymerization reaction Methods 0.000 claims description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 6
- 229910044991 metal oxide Inorganic materials 0.000 claims description 3
- 150000004706 metal oxides Chemical class 0.000 claims description 3
- -1 polysiloxane chain Polymers 0.000 description 34
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 19
- 239000006185 dispersion Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 239000006096 absorbing agent Substances 0.000 description 14
- 230000000475 sunscreen effect Effects 0.000 description 14
- 239000000516 sunscreening agent Substances 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 239000004408 titanium dioxide Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 229960005150 glycerol Drugs 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000010445 mica Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 4
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- KLPCZNSIPDGAJJ-UHFFFAOYSA-N 2-methoxy-3,3-dimethyl-1-phenylbutan-1-one Chemical compound COC(C(C)(C)C)C(=O)C1=CC=CC=C1 KLPCZNSIPDGAJJ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- MZZSDCJQCLYLLL-UHFFFAOYSA-N Secalonsaeure A Natural products COC(=O)C12OC3C(CC1=C(O)CC(C)C2O)C(=CC=C3c4ccc(O)c5C(=O)C6=C(O)CC(C)C(O)C6(Oc45)C(=O)OC)O MZZSDCJQCLYLLL-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229910000423 chromium oxide Inorganic materials 0.000 description 2
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 2
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229960003921 octisalate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LTSWUFKUZPPYEG-UHFFFAOYSA-N 1-decoxydecane Chemical compound CCCCCCCCCCOCCCCCCCCCC LTSWUFKUZPPYEG-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920006310 Asahi-Kasei Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical group [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000004447 silicone coating Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Description
本発明は、表面処理された粉体に関し、また、該表面処理された粉体を含有する皮膚外用剤に関する。 The present invention relates to a surface-treated powder, and also relates to a skin external preparation containing the surface-treated powder.
化粧料、特にメークアップ化粧料には、シミ、ソバカス等の肌トラブルをカバーし、肌色を健康的に見せる等のメークアップ効果や塗布時にさっぱり感を感じる等の良好な使用感が求められている。優れたメークアップ効果を得るためには、これら効果を担う、有色顔料がメークアップ化粧料中に均一に分散し、この分散状態が長期にわたって保たれることが必要とされている。また、良好な使用感を得るためにも同様な特性が必要とされている。 Cosmetics, especially makeup cosmetics, are required to have a good feeling of use, such as covering skin troubles such as spots and freckles, making the skin color healthy, and feeling refreshed when applied. Yes. In order to obtain an excellent make-up effect, it is necessary that the colored pigments responsible for these effects are uniformly dispersed in the make-up cosmetic and the dispersion state is maintained for a long time. Moreover, in order to obtain a good feeling of use, similar characteristics are required.
有色顔料や体質顔料の分散性や、分散安定性を向上させるための試みとして、側鎖にポリシロキサン鎖を有するアクリル重合体で被覆した顔料を乳化剤型化粧料に配合することで、化粧料中の顔料の分散性が向上し、優れた化粧持ちとさっぱりした使用感が得られるという技術が知られている(例えば特許文献1、2参照)。 As an attempt to improve the dispersibility and dispersion stability of colored pigments and extender pigments, by incorporating a pigment coated with an acrylic polymer having a polysiloxane chain in the side chain into an emulsifier type cosmetic, A technique is known in which the dispersibility of the pigment is improved, and an excellent makeup and a refreshing feeling of use can be obtained (see, for example, Patent Documents 1 and 2).
また、A領域、及びB領域の紫外線吸収剤を配合した乳化化粧料に、側鎖にポリシロキサン鎖を有するアクリル重合体で被覆した顔料を配合することで、顔料の分散性を向上させ、結果として、化粧持ち及びA領域、B領域の紫外線の防御効果に優れる乳化化粧料が得られるという技術も知られている(例えば特許文献3参照)。 Moreover, the dispersibility of the pigment is improved by blending the pigment coated with the acrylic polymer having a polysiloxane chain in the side chain into the emulsified cosmetic blended with the ultraviolet absorbers in the A region and the B region. In addition, a technique is known in which an emulsified cosmetic material having excellent makeup protection and an ultraviolet protection effect in the A region and the B region is obtained (see, for example, Patent Document 3).
しかしながら、これらの技術に於いては、長期間保存した場合に顔料の分散性が低下する場合があるという課題が存在していた。
本発明は、紫外線吸収剤を配合させた皮膚外用剤において、良好な分散性が長期間にわたって維持される、粉体の分散安定性に優れた皮膚外用剤を提供することを課題とする。
However, in these techniques, there has been a problem that the dispersibility of the pigment may deteriorate when stored for a long period of time.
This invention makes it a subject to provide the skin external preparation excellent in the dispersion stability of powder in which the favorable dispersibility is maintained over a long period in the skin external preparation which mix | blended the ultraviolet absorber.
本発明者らは、上記課題を解決すべく検討したところ、従来提案されている技術では、含有させた顔料の分散安定性が未だ十分ではないために、メークアップ効果や使用感が更に改善され得ることがわかった。そこで、顔料などの粉体の分散安定性を向上させるべく、粉体の表面処理方法を検討したところ、(a)特定の構造を有する反応性オルガノポリシロキサン、及び(b)少なくとも1つのフェニル基を有するオルガノポリシロキサンで粉体表面を処理することで、上記課題を解決できることを見出し、本発明を完成させた。 The inventors of the present invention have studied to solve the above-mentioned problems, and in the conventionally proposed technology, since the dispersion stability of the contained pigment is not yet sufficient, the makeup effect and the feeling of use are further improved. I knew I would get it. Then, in order to improve the dispersion stability of powders such as pigments, a surface treatment method for powders was studied. (A) Reactive organopolysiloxane having a specific structure, and (b) at least one phenyl group. The present invention has been completed by finding that the above-mentioned problems can be solved by treating the powder surface with an organopolysiloxane having bismuth.
本発明の第一の実施態様は、以下のとおりである。
(1)(a)重合度が25以上100以下、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値が1以上1.3以下であって、少なくとも一方の分子鎖末端にアルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される少なくと
も1種を有する直鎖状の反応性オルガノポリシロキサン、及び(b)少なくとも1つのフェニル基を有するオルガノポリシロキサンで被覆された、平均一次粒子径が100nm以上の粉体。
(2)前記(b)少なくとも1つのフェニル基を有するオルガノポリシロキサンが、下記一般式(3)で表される(1)に記載の粉体。
(3)前記式(3)において、R3は独立して、炭素数1〜3のアルキル基、及び炭素数1〜3のアルコキシ基から選択され、R4は独立して炭素数1〜3のアルキル基、下記一般式(4)で表される基及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する、(2)に記載の粉体。
(4)前記式(3)において、R3は独立して、炭素数1〜3のアルキル基から選択され、R4は独立して炭素数1〜3のアルキル基、下記一般式(4)で表される基及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する、(2)または(3)に記載の粉体。
(5)前記粉体は、金属酸化物、無機有色顔料、体質顔料、及び無機光輝性顔料から選択される少なくとも1種を含む、(1)〜(4)のいずれかに記載の粉体。
The first embodiment of the present invention is as follows.
(1) (a) The degree of polymerization is 25 or more and 100 or less, the ratio Mw / Mn between the weight average molecular weight Mw and the number average molecular weight Mn is 1 or more and 1.3 or less, and at least one molecular chain terminal is alkoxylated A linear reactive organopolysiloxane having at least one selected from the group consisting of a group, a hydroxyl group, a halogen atom, an amino group and an imino group, and (b) an organopolysiloxane having at least one phenyl group A powder having an average primary particle diameter of 100 nm or more.
(2) The powder according to (1), wherein (b) the organopolysiloxane having at least one phenyl group is represented by the following general formula (3).
(3) In the formula (3), R 3 is independently selected from an alkyl group having 1 to 3 carbon atoms and an alkoxy group having 1 to 3 carbon atoms, and R 4 is independently selected from 1 to 3 carbon atoms. The powder according to (2), wherein the powder is selected from an alkyl group of the following formula, a group represented by the following general formula (4), and a phenyl group, and having at least one unit having a phenyl group.
(4) In the formula (3), R 3 is independently selected from an alkyl group having 1 to 3 carbon atoms, R 4 is independently an alkyl group having 1 to 3 carbon atoms, and the following general formula (4) The powder according to (2) or (3), which is selected from the group represented by the formula (1) and a phenyl group and has at least one unit having a phenyl group.
(5) The powder according to any one of (1) to (4), wherein the powder includes at least one selected from metal oxides, inorganic colored pigments, extender pigments, and inorganic bright pigments.
また、本発明の第二の実施態様は、以下のとおりである。
(6)(1)〜(5)のいずれかに記載の粉体、及び紫外線吸収剤を含有する皮膚外用剤。
(7)A領域の紫外線を吸収する紫外線吸収剤、及びB領域の紫外線を吸収する紫外線吸収剤、を含有する(6)に記載の皮膚外用剤。
(8)化粧料である、(6)または(7)に記載の皮膚外用剤。
The second embodiment of the present invention is as follows.
(6) A skin external preparation containing the powder according to any one of (1) to (5) and an ultraviolet absorber.
(7) The skin external preparation described in (6), which contains an ultraviolet absorber that absorbs ultraviolet rays in the A region and an ultraviolet absorber that absorbs ultraviolet rays in the B region.
(8) The external preparation for skin according to (6) or (7), which is a cosmetic.
本発明によれば、紫外線吸収剤を配合させた皮膚外用剤において、良好な分散性が長期間にわたって維持される、粉体の分散安定性に優れた皮膚外用剤を提供することができる。また、本発明の皮膚外用剤中に配合される粉体は、油剤中での分散性が良好であり、経時で粉体が凝集することがなく、離奨が生じにくいため、本発明の皮膚外用剤は経時でメークアップ効果や使用感が低下しない。 ADVANTAGE OF THE INVENTION According to this invention, the skin external preparation which was excellent in the dispersion stability of the powder in which favorable dispersibility is maintained over a long period can be provided in the skin external preparation which mix | blended the ultraviolet absorber. In addition, the powder blended in the external preparation for skin of the present invention has good dispersibility in an oil agent, the powder does not aggregate over time, and is not likely to be recommended. The external preparation does not deteriorate the make-up effect and the feeling of use over time.
本発明の第一の実施態様は、2種類のオルガノポリシロキサンで表面処理された粉体である。
本実施態様に用いる粉体は、電子顕微鏡観察による一次粒子径が通常100nm以上であって、皮膚外用剤に配合し得る粉体であればよい。粉体の例示としては、酸化チタン、酸化亜鉛、酸化ジルコニウム、酸化セリウム等の金属酸化物;ベンガラ、黄色酸化鉄、黒色酸化鉄、酸化クロム、水酸化クロム等の有色無機顔料;硫酸バリウム、タルク、セリサイト、カオリン、マイカ、無水珪酸、窒素化硼素、アルミナ等の体質顔料;チタンマイカ等の無機光輝性顔料等があげられる。これらの粉体は、その表面がシリカ、アルミナ等の無機化合物、または脂肪酸金属石鹸、シリコーン等の有機化合物により被覆されてもよい。
The first embodiment of the present invention is a powder surface-treated with two types of organopolysiloxanes.
The powder used in this embodiment may be any powder that has a primary particle size of usually 100 nm or more as observed by an electron microscope and can be blended in a skin external preparation. Examples of powders include metal oxides such as titanium oxide, zinc oxide, zirconium oxide and cerium oxide; colored inorganic pigments such as bengara, yellow iron oxide, black iron oxide, chromium oxide and chromium hydroxide; barium sulfate and talc And extender pigments such as sericite, kaolin, mica, silicic anhydride, boron nitride and alumina; and inorganic bright pigments such as titanium mica. The surface of these powders may be coated with an inorganic compound such as silica or alumina, or an organic compound such as fatty acid metal soap or silicone.
本実施態様に用いる粉体は、電子顕微鏡観察による一次粒子径が100nm以上であり、化粧料分野における微粒子とは区別されるものである。本実施態様に用いる粉体の平均一次粒径は、好ましくは150nm以上、より好ましくは200nm以上、また通常10μm以下、好ましくは5μm以下、より好ましくは3μm以下である。
本実施態様で用いられる粉体としては、メークアップ効果や良好な使用感を与える役割を担うことから、酸化チタン、ベンガラ、黄色酸化鉄、黒色酸化鉄、酸化クロム、水酸化クロム等の有色無機顔料、タルク、セリサイト、マイカであることが好ましい。
The powder used in this embodiment has a primary particle diameter of 100 nm or more as observed with an electron microscope, and is distinguished from fine particles in the cosmetics field. The average primary particle size of the powder used in this embodiment is preferably 150 nm or more, more preferably 200 nm or more, and usually 10 μm or less, preferably 5 μm or less, more preferably 3 μm or less.
As the powder used in this embodiment, since it plays a role of giving a make-up effect and good usability, colored inorganic such as titanium oxide, bengara, yellow iron oxide, black iron oxide, chromium oxide, chromium hydroxide, etc. Pigments, talc, sericite and mica are preferred.
本実施態様で用いる粉体の入手には特段困難性はなく、市販されている粉体を適宜用いればよい。 There is no particular difficulty in obtaining the powder used in this embodiment, and a commercially available powder may be used as appropriate.
本実施態様に係る粉体は、(a)特定の構造を有する反応性オルガノポリシロキサン、及び(b)少なくとも1つのフェニル基を有するオルガノポリシロキサンで被覆される。
本発明者らは、粉体を上記(a)、(b)2種類のオルガノポリシロキサンで被覆することで、紫外線吸収剤を含む分散媒中における分散性が改善され、皮膚外用剤とした際に粉体の分散安定性に優れるため、メークアップ効果が持続し、かつ、使用感も良いことに想到した。
The powder according to this embodiment is coated with (a) a reactive organopolysiloxane having a specific structure, and (b) an organopolysiloxane having at least one phenyl group.
The present inventors have improved the dispersibility in a dispersion medium containing an ultraviolet absorber by coating the powder with the above-mentioned two types of (a) and (b) organopolysiloxanes. In addition, it was conceived that the make-up effect was sustained and the feeling of use was good because of excellent dispersion stability of the powder.
(a)オルガノポリシロキサンは、直鎖状の反応性オルガノポリシロキサンであり、重合度が25以上100以下、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値が1以上1.3以下であって、少なくとも一方の分子鎖末端にアルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される少なくとも1種を有する。
アルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される反応基は少なくとも一方の分子鎖末端に存在すればよく、両方の分子鎖末端に存在してもよいが、粉体との反応性等の観点からは、一方のみの分子鎖末端にこれらの反応基のうち少なくとも1種が存在すればよい。
アルコキシ基としては、炭素数が1以上5以下のものが好ましく、炭素数が1以上3以下のもの、すなわちメトキシ基、エトキシ基、プロポキシ基がより好ましい。
ハロゲン原子としては、塩素、臭素、ヨウ素等が好ましい。
(A) The organopolysiloxane is a linear reactive organopolysiloxane having a degree of polymerization of 25 to 100 and a ratio Mw / Mn of the weight average molecular weight Mw to the number average molecular weight Mn of 1 to 1. 3 or less, and at least one molecular chain terminal has at least one selected from the group consisting of an alkoxy group, a hydroxyl group, a halogen atom, an amino group, and an imino group.
The reactive group selected from the group consisting of an alkoxy group, a hydroxyl group, a halogen atom, an amino group and an imino group may be present at at least one molecular chain end, and may be present at both molecular chain ends. From the standpoint of reactivity and the like, at least one of these reactive groups may be present at only one molecular chain end.
As an alkoxy group, a C1-C5 thing is preferable and a C1-C3 thing, ie, a methoxy group, an ethoxy group, and a propoxy group are more preferable.
As the halogen atom, chlorine, bromine, iodine and the like are preferable.
本実施態様に用いられる(a)反応性オルガノポリシロキサンは、重合度が25以上100以下である。好ましくは30以上である。また、60以下であることが好ましく、50以下であることがより好ましい。
重合度をこの範囲とすることで、化粧料に配合した際の使用性、及び粉体との反応性が良好となる。
The degree of polymerization of the (a) reactive organopolysiloxane used in this embodiment is 25 or more and 100 or less. Preferably it is 30 or more. Moreover, it is preferable that it is 60 or less, and it is more preferable that it is 50 or less.
By making the degree of polymerization within this range, the usability when blended into a cosmetic and the reactivity with the powder are improved.
本実施態様に用いられる(a)反応性オルガノポリシロキサンは、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値(以下、分子量分散度ともいう)が1以上1.3以下である。Mw/Mnの値がこの範囲内にあることで、分子量分布がシャープとなり、化粧料に配合した際に良好な使用感が得やすくなる。重量平均分子量と数平均分子量は、例えばGPC(ゲルパーミエーションクロマトグラフィー)により求めることができる。 The (a) reactive organopolysiloxane used in this embodiment has a ratio Mw / Mn (hereinafter also referred to as molecular weight dispersity) of the weight average molecular weight Mw and the number average molecular weight Mn of 1 or more and 1.3 or less. is there. When the value of Mw / Mn is within this range, the molecular weight distribution becomes sharp, and it is easy to obtain a good feeling when used in cosmetics. The weight average molecular weight and the number average molecular weight can be determined by GPC (gel permeation chromatography), for example.
本実施態様に用いられる(a)反応性オルガノポリシロキサンの具体例としては、以下の一般式(1)および(2)で表されるポリオルガノシロキサンがあげられる。
上記式(1)および(2)中、R1は独立して、炭素数1〜3のアルキル基から選択される。炭素数1〜3のアルキル基とは、メチル基、エチル基、プロピル基である。
上記式(1)中、R2は独立して、アルキル基、アルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択され、R2のうち少なくとも1つは、アルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される反応基である。アルコキシ基としては、炭素数1〜3のアルコキシ基であることが好ましく、メトキシ基、エトキシ基、プロポキシ基が好ましい。ハロゲン原子としては、塩素、臭素、ヨウ素が好ましい。
Rは独立して、単結合、及び二価の炭化水素基から選択され、二価の炭化水素基である場合には、その水素原子が水酸基、メトキシ基、エトキシ基、メチル基、又はエチル基で置換されていてもよい。二価の炭化水素基としては、メチレン基、エチレン基、プロペン基等が例示される。
mは通常25以上、好ましくは30以上であり、また、通常100以下、好ましくは60以下であり、より好ましくは50以下である。
In the above formulas (1) and (2), R 1 is independently selected from alkyl groups having 1 to 3 carbon atoms. A C1-C3 alkyl group is a methyl group, an ethyl group, and a propyl group.
In the above formula (1), R 2 is independently selected from the group consisting of an alkyl group, an alkoxy group, a hydroxyl group, a halogen atom, an amino group, and an imino group, and at least one of R 2 is an alkoxy group, a hydroxyl group , A reactive group selected from the group consisting of a halogen atom, an amino group and an imino group. As an alkoxy group, it is preferable that it is a C1-C3 alkoxy group, and a methoxy group, an ethoxy group, and a propoxy group are preferable. As the halogen atom, chlorine, bromine and iodine are preferable.
R is independently selected from a single bond and a divalent hydrocarbon group, and when it is a divalent hydrocarbon group, the hydrogen atom is a hydroxyl group, a methoxy group, an ethoxy group, a methyl group, or an ethyl group May be substituted. Examples of the divalent hydrocarbon group include a methylene group, an ethylene group, and a propene group.
m is usually 25 or more, preferably 30 or more, and is usually 100 or less, preferably 60 or less, more preferably 50 or less.
上記(a)反応性オルガノポリシロキサンの更なる具体例としては、例えば、ジメチルポリシロキシシラザン、α−モノヒドロキシシロキサン、α,ω−ジヒドロキシポリジメチルシロキサン、α−モノアルコキシポリジメチルシロキサン、α−ジアルコキシポリジメチルシロキサン、α−トリアルコキシポリジメチルシロキサン、α,ω−ジアルコキシジメチルポリシロキサン、α,ω−ヘキサアルコキシポリジメチルポリシロキサン、ジメチルポリシロキシクロライド、ジメチルポリシロキシブロミド、及びジメチルポリシロキシイオジド等が挙げられる。
中でも、α−モノアルコキシポリジメチルシロキサン、α−ジアルコキシポリジメチルシロキサン及びα−トリアルコキシポリジメチルシロキサン(例として、α−トリエトキシポリジメチルシロキサン等)が、反応性が非常に良好であり、特に滑らかな感触を付与するので好ましい。
As further specific examples of the above-mentioned (a) reactive organopolysiloxane, for example, dimethylpolysiloxysilazane, α-monohydroxysiloxane, α, ω-dihydroxypolydimethylsiloxane, α-monoalkoxypolydimethylsiloxane, α-di Alkoxypolydimethylsiloxane, α-trialkoxypolydimethylsiloxane, α, ω-dialkoxydimethylpolysiloxane, α, ω-hexaalkoxypolydimethylpolysiloxane, dimethylpolysiloxane chloride, dimethylpolysiloxybromide, and dimethylpolysiloxy iodide Etc.
Among them, α-monoalkoxypolydimethylsiloxane, α-dialkoxypolydimethylsiloxane and α-trialkoxypolydimethylsiloxane (for example, α-triethoxypolydimethylsiloxane) have very good reactivity. This is preferable because it provides a smooth feel.
上記(b)オルガノポリシロキサンは、フェニル基を有するオルガノポリシロキサンである。(b)オルガノポリシロキサンはフェニル基を有する限り特段その種類は限定されず、例えば、下記一般式(3)で表されるオルガノポリシロキサンを例示できる。 The (b) organopolysiloxane is an organopolysiloxane having a phenyl group. (B) As long as the organopolysiloxane has a phenyl group, the type thereof is not particularly limited, and examples thereof include organopolysiloxanes represented by the following general formula (3).
上記式(3)中、R3は独立して、水素、炭素数1〜3のアルキル基、及び炭素数1〜3のアルコキシ基から選択される。好ましくは、R3は独立して、炭素数1〜3のアルキル基、及び炭素数1〜3のアルコキシ基から選択され、より好ましくは、R3は独立して、炭素数1〜3のアルキル基から選択される。
R4は独立して水素、炭素数1〜3のアルキル基、下記一般式(4)で表される基及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する。好ましくは、R4は独立して炭素数1〜3のアルキル基、及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する。
nは整数であり、通常3以上、好ましくは5以上、また通常600以下、好ましくは400以下である。
R 4 is independently selected from hydrogen, an alkyl group having 1 to 3 carbon atoms, a group represented by the following general formula (4), and a phenyl group, and has at least one unit having a phenyl group. Preferably, R 4 is independently selected from an alkyl group having 1 to 3 carbon atoms and a phenyl group, and has at least one unit having a phenyl group.
n is an integer and is usually 3 or more, preferably 5 or more, and usually 600 or less, preferably 400 or less.
上記(b)オルガノポリシロキサンに含まれる好ましい具体例としては、モノフェニルジメチコン、ジフェニルジメチコン、ジフェニルシロキシフェニルトリメチコン、トリメチルシロキシフェニルジメチコンなどがあげられる。これらは定法に従い調製することもできるが、市販品を用いてもよい。
市販品としては、「シリコーンKF54」(信越化学株式会社製)、「シリコーンKF56」(信越化学株式会社製)、「BELSEL PDM 1000」(旭化成ワッカーシリコーン株式会社製)等が例示される。
上記(b)オルガノポリシロキサンの数平均分子量は特段限定されないが、通常500以上、好ましくは800以上、また通常100000以下、好ましくは80000以下である。
Preferable specific examples contained in the (b) organopolysiloxane include monophenyl dimethicone, diphenyl dimethicone, diphenylsiloxyphenyl trimethicone, trimethylsiloxyphenyl dimethicone and the like. These can be prepared according to conventional methods, but commercially available products may also be used.
Examples of commercially available products include “silicone KF54” (manufactured by Shin-Etsu Chemical Co., Ltd.), “silicone KF56” (manufactured by Shin-Etsu Chemical Co., Ltd.), “BELSEL PDM 1000” (manufactured by Asahi Kasei Wacker Silicone Co., Ltd.), and the like.
The number average molecular weight of the (b) organopolysiloxane is not particularly limited, but is usually 500 or more, preferably 800 or more, and usually 100,000 or less, preferably 80000 or less.
上記(a)及び(b)のオルガノポリシロキサンによる、粉体の表面処理は、定法に従い処理されれば良く、例えば必要により溶媒を用いて、ヘンシェルミキサー等の混合機により粉体とオルガノポリシロキサンを混合し、該混合物を加熱する等の方法があげられる。また、上記(a)及び(b)のオルガノポリシロキサンによる処理の順序についても特段限定されないが、(a)のオルガノポリシロキサンで表面処理を行った後に、(b)のオルガノポリシロキサンで処理することで、本発明の効果がより顕著なものとなり、好ましい。 The surface treatment of the powder with the organopolysiloxanes (a) and (b) may be performed according to a conventional method. For example, the powder and the organopolysiloxane are mixed with a mixer such as a Henschel mixer, if necessary, using a solvent. And a method of heating the mixture. Further, the order of the treatment with the organopolysiloxanes (a) and (b) is not particularly limited, but after the surface treatment with the organopolysiloxane (a), the treatment with the organopolysiloxane (b) is performed. Thus, the effect of the present invention becomes more remarkable and preferable.
本実施態様に係る粉体において、上記(a)及び(b)のオルガノポリシロキサンの被覆量は、表面処理後の粉体に対し、それぞれ通常0.5質量%以上、好ましくは1質量%以上であり、また、通常15質量%以下、好ましくは10質量%以下である。オルガノポリシロキサンによる被覆量をこの範囲とすることで、本実施態様に係る粉体の分散性がより良好となり、皮膚外用剤に配合した際に粉体の分散安定性に優れるため、メークアップ効果が持続し、使用感も良好となる。 In the powder according to this embodiment, the coating amount of the organopolysiloxanes (a) and (b) is usually 0.5% by mass or more, preferably 1% by mass or more, respectively, with respect to the powder after the surface treatment. Moreover, it is 15 mass% or less normally, Preferably it is 10 mass% or less. By making the coating amount with the organopolysiloxane within this range, the dispersibility of the powder according to the present embodiment becomes better, and the dispersion stability of the powder when blended into the external preparation for skin is improved. Will continue and the feeling will be good.
また、(a)及び(b)のオルガノポリシロキサンの被覆量の比は特段限定されず、通常質量比で(a):(b)=95:5〜5:95であり、好ましくは80:20〜20;80、より好ましくは70:30〜30:70である。 Moreover, the ratio of the coating amount of the organopolysiloxane (a) and (b) is not particularly limited, and is usually (a) :( b) = 95: 5 to 5:95, preferably 80: 20-20; 80, more preferably 70: 30-30: 70.
本発明の第二の実施態様は、上記第一の実施態様に係る粉体、及び紫外線吸収剤を含有する皮膚外用剤である。
本実施態様に係る皮膚外用剤において、上記第一の実施態様に係る粉体の配合量は特段限定されず、化粧料の種類により適宜設定可能であるが、皮膚外用剤全量に対し、通常1質量%以上、好ましくは2質量%以上であり、また、通常70質量%以下、好ましくは50質量%以下、より好ましくは30質量%以下である。
紫外線吸収剤としては、皮膚外用剤に配合し得る紫外線吸収剤であれば特段限定されないが、幅広い波長の紫外線を吸収するために、320〜400nm波長(A領域)の紫外線を吸収するUV−A吸収剤、及び290〜320nm波長(B領域)の紫外線を吸収するUV−B吸収剤を含むことが好ましい。
紫外線吸収剤の配合量は特段限定されず、皮膚外用剤全量に対し、通常0.01質量%以上、好ましくは0.1質量%以上であり、また、通常25質量%以下、好ましくは20質量%以下である。
The second embodiment of the present invention is a skin external preparation containing the powder according to the first embodiment and an ultraviolet absorber.
In the external preparation for skin according to this embodiment, the blending amount of the powder according to the first embodiment is not particularly limited and can be appropriately set depending on the type of cosmetic, but is usually 1 for the total amount of external preparation for skin. It is at least mass%, preferably at least 2 mass%, and is usually at most 70 mass%, preferably at most 50 mass%, more preferably at most 30 mass%.
The ultraviolet absorber is not particularly limited as long as it is an ultraviolet absorber that can be blended into a skin external preparation, but UV-A that absorbs ultraviolet rays having a wavelength of 320 to 400 nm (A region) in order to absorb ultraviolet rays having a wide range of wavelengths. It is preferable to include an absorber and a UV-B absorber that absorbs ultraviolet rays having a wavelength of 290 to 320 nm (B region).
The compounding quantity of a ultraviolet absorber is not specifically limited, It is 0.01 mass% or more normally with respect to the skin external preparation whole quantity, Preferably it is 0.1 mass% or more, and is 25 mass% or less normally, Preferably it is 20 mass. % Or less.
UV−A吸収剤としては、2−ヒドロキシ−4−メトキシベンゾフェノン、2−(2´−ヒドロキシ−5´−メチルフェニル)ベンゾトリアゾール、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2−エチルヘキシル、ビス(レスルシニル)トリアジン、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノール、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、t−ブチルメトキシベンゾイルメタン等の化合物
が例示される。この内でも、紫外線吸収能に優れることから、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、及びt−ブチルメトキシベンゾイルメタンが特に好ましい。これらの化合物には市販品が存在するので、市販品をそのまま用いることができる。具体的な市販品としては「ユビナールAプラス グラニュラー」(ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル BASF社製)、「パルソール1789」(t−ブチルメトキシベンゾイルメタン DSM社製)が例示できる。
Examples of UV-A absorbers include 2-hydroxy-4-methoxybenzophenone, 2- (2′-hydroxy-5′-methylphenyl) benzotriazole, dimethoxybenzylidenedioxoimidazolidinepropionate 2-ethylhexyl, and bis (reslucinyl). Examples include triazine, methylenebisbenzotriazolyltetramethylbutylphenol, hexyl diethylaminohydroxybenzoyl benzoate, t-butylmethoxybenzoylmethane, and the like. Among these, diethylaminohydroxybenzoyl hexyl benzoate and t-butylmethoxybenzoylmethane are particularly preferable because of their excellent ultraviolet absorbing ability. Since these compounds have commercial products, commercial products can be used as they are. Specific commercial products include “Ubinal A Plus Granular” (diethylaminohydroxybenzoyl hexyl benzoate manufactured by BASF) and “Pulsol 1789” (manufactured by t-butylmethoxybenzoylmethane DSM).
UV−A吸収剤の含有量は、皮膚外用剤全量に対して通常0.01質量%以上、好ましくは0.1質量%以上であり、また、通常5質量%以下、好ましくは3質量%以下である。 The content of the UV-A absorber is usually 0.01% by mass or more, preferably 0.1% by mass or more, and usually 5% by mass or less, preferably 3% by mass or less, based on the total amount of the external preparation for skin. It is.
UV−B吸収剤としては、具体的には、パラメトキシ桂皮酸2−エチルヘキシル、2−シアノ−3,3−ジフェニルアクリル酸2−エチルヘキシル、ジメチコジエチルベンザルマロネート、2,4,6−トリアニリノ−p−(カルボ−2´−エチルヘキシル−1´−オキシ)−1,3,5−トリアジン、2−ヒドロキシ−4−メトキシベンゾフェノン、サリチル酸ホモメンチル、サリチル酸オクチル等の化合物があげられる。これらの化合物には市販品が存在するので、市販品をそのまま用いることができる。具体的な市販品としては、「ユビナールMC80」(パラメトキシ桂皮酸2−エチルヘキシル BASF社製)、「ユビナールT150」(2,4,6−トリアニリノ−p−(カルボ−2´−エチルヘキシル−1´−オキシ)−1,3,5−トリアジン BASF社製)、「ユビナールM40」(2−ヒドロキシ−4−メトキシベンゾフェノン BASF社製)、「パルソールSLX」(ジメチコジエチルベンザルマロネート DSM社製)、「パルソール340」(2−シアノ−3,3−ジフェニルアクリル酸2−エチルヘキシル DSM社製)、「パルソールHMS」(サリチル酸ホモメンチル DSM社製)、「パルソールEMS」(サリチル酸オクチル DSM社製)が例示できる。 Specific examples of the UV-B absorber include 2-methoxyhexyl paramethoxycinnamate, 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, dimethicodiethylbenzalmalonate, 2,4,6-trianilino Examples include -p- (carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazine, 2-hydroxy-4-methoxybenzophenone, homomenthyl salicylate, octyl salicylate and the like. Since these compounds have commercial products, commercial products can be used as they are. Specific commercial products include “Ubinal MC80” (2-ethylhexyl paramethoxycinnamate, manufactured by BASF), “Ubinal T150” (2,4,6-trianilino-p- (carbo-2′-ethylhexyl-1′-). Oxy) -1,3,5-triazine (made by BASF), “Ubinal M40” (made by 2-hydroxy-4-methoxybenzophenone BASF), “Pulsol SLX” (made by dimethicodiethylbenzalmalonate DSM), “Pulsol 340” (2-ethylhexyl 2-cyano-3,3-diphenylacrylate, manufactured by DSM), “Pulsol HMS” (homomothyl salicylate, manufactured by DSM), “Pulsol EMS” (made by octyl salicylate, DSM) can be exemplified. .
UV−B吸収剤の含有量は、皮膚外用剤全量に対して通常0.1質量%以上、好ましくは0.5質量%以上であり、また、通常10質量%以下、好ましくは7質量%以下である。上記範囲の含有量により、より良好に紫外線吸収効果を発揮できる。 The content of the UV-B absorber is usually 0.1% by mass or more, preferably 0.5% by mass or more, and usually 10% by mass or less, preferably 7% by mass or less, based on the total amount of the external preparation for skin. It is. With the content in the above range, the ultraviolet absorption effect can be exhibited better.
本実施態様に係る皮膚外用剤は、皮膚に外用で投与されるものであれば特段の限定はなく、例えば、医薬部外品を包含する化粧料、皮膚外用雑貨等が好適に例示できる。化粧料として用いられることがより好ましい。
本実施態様に係る皮膚外用剤は、通常知られている、乳液剤形、エッセンス剤形、クリーム剤形、粉体含有剤形の何れをも取ることが出来る。化粧料としては、基礎化粧料、毛髪化粧料、メークアップ化粧料などの何れもが適用可能であるが、紫外線吸収効果を有するメークアップ化粧料に適用することが特に好ましい。
The skin external preparation according to this embodiment is not particularly limited as long as it is externally administered to the skin, and examples thereof include cosmetics including quasi-drugs, and skin external goods. More preferably, it is used as a cosmetic.
The external preparation for skin according to this embodiment may take any of the conventionally known emulsion dosage forms, essence dosage forms, cream dosage forms, and powder-containing dosage forms. The cosmetics, basic cosmetics, hair cosmetics, but any such makeup cosmetics can be applied, it is particularly preferable to apply the makeup cosmetic having an ultraviolet absorption Osamuko fruit.
本実施態様に係る皮膚外用剤に於いては、前記の成分以外に、通常化粧料や皮膚外用医薬で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば:マカデミアナッツ油、アボカド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;
流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;
オレイン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;
セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコ
ール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール類;
イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;
ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;
脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;
塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;
ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、アシルメチルタウリン等の両性界面活性剤類;
ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等) 、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコー
ル脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキシエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等) 、POEアルキルエ
ーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;
ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキシレングリコール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;
ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;
グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸、ローカストビーンガム、サクシノグルカン、カロニン酸,キチン、キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレ
ングリコール、ベントナイト等の増粘剤;
表面を処理されていてもよい、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類;
表面を処理されていてもよい、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;
表面を処理されていてもよい、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;
レーキ化されていてもよい赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;
ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;
パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤、糖系紫外線吸収剤、2−(2'−ヒドロキシ−5'−t−オクチルフェニル)ベンゾトリアゾール、4−メトキ
シ−4'−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;
エタノール、イソプロパノール等の低級アルコール類;
ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類、α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類;
などが好ましく例示できる。
In the external preparation for skin according to this embodiment, in addition to the above-described components, optional components that are usually used in cosmetics and external preparations for skin can be contained. Such optional ingredients include, for example: macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, palm oil, palm oil, liquid lanolin, hydrogenated coconut oil Oils such as hardened oil, mole, hardened castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes;
Hydrocarbons such as liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum, microcrystalline wax;
Higher fatty acids such as oleic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid;
Higher alcohols such as cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol;
Cetyl isooctanoate, isopropyl myristate, hexyl decyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, diisostearyl malate, ethylene glycol di-2-ethylhexanoate, neopentyl glycol dicaprate, Synthetic esters such as glycerin di-2-heptylundecanoate, glyceryl tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, pentane erythritol tetra-2-ethylhexanoate Oils;
Linear polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified poly Oil agents such as silicone oil such as siloxane, alkyl-modified polysiloxane, and modified polysiloxane such as fluorine-modified polysiloxane;
Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, alkylsulfuric acid triethanolamine ether;
Cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, laurylamine oxide;
Betaine surfactants (alkyl betaines, amide betaines, sulfobetaines, etc.), imidazoline amphoteric surfactants (such as 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt), acylmethyl taurine Amphoteric surfactants such as;
Sorbitan fatty acid esters (such as sorbitan monostearate and sorbitan sesquioleate), glycerin fatty acids (such as glyceryl monostearate), propylene glycol fatty acid esters (such as propylene glycol monostearate), hydrogenated castor oil derivatives, glycerin alkyl ether POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin monoisosteare) Rate), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyl) Decyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl ether, etc.), pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), tetronics, POE castor oil / cured castor Nonionic surfactants such as oil derivatives (POE castor oil, POE hydrogenated castor oil, etc.), sucrose fatty acid esters, alkyl glucosides;
Polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexylene glycol, 1 Polyhydric alcohols such as 1,2-hexanediol and 1,2-octanediol;
Moisturizing ingredients such as sodium pyrrolidonecarboxylate, lactic acid, sodium lactate;
Gua gum, quince seed, carrageenan, galactan, arabic gum, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, Sodium hyaluronate, gum tragacanth, keratan sulfate, chondroitin, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran, kerato sulfate, locust bean gum, succinoglucan, carolinic acid, chitin, chitosan, carboxymethyl chitin, agar, polyvinyl alcohol , Polyvinylpyrrolidone, carboxyvinyl polymer, alkyl-modified carboxyl Vinyl polymers, sodium polyacrylate, polyethylene glycol, bentonite thickener;
Powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate, etc. whose surface may be treated;
Inorganic pigments such as bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide, the surface of which may be treated;
Pearl agents such as titanium mica, fish phosphorus foil, bismuth oxychloride, etc. whose surface may be treated;
Red 202, Red 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201, Red 213 which may be raked Organic dyes such as Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204;
Organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer;
Paraaminobenzoic acid UV absorbers, anthranilic acid UV absorbers, salicylic acid UV absorbers, cinnamic acid UV absorbers, benzophenone UV absorbers, sugar UV absorbers, 2- (2'-hydroxy-5 ' UV absorbers such as -t-octylphenyl) benzotriazole, 4-methoxy-4'-t-butyldibenzoylmethane;
Lower alcohols such as ethanol and isopropanol;
Vitamin A or a derivative thereof, vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 or a derivative thereof, vitamin B 12 such as vitamin B 12 , vitamin B 15 or a derivative thereof, α-tocopherol , Β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone and other vitamins;
Etc. can be preferably exemplified.
以下、実施例を用いて本発明をより詳細に説明するが、本発明が以下の実施例のみに限定されないことはいうまでもない。 EXAMPLES Hereinafter, although this invention is demonstrated in detail using an Example, it cannot be overemphasized that this invention is not limited only to a following example.
<実施例1>シリコーン被覆顔料級二酸化チタンの製造例1
顔料級二酸化チタン85g(平均一次粒子径0.3μm)、反応性ポリオルガノシロキサンとしてα−トリエトキシポリメチルポリシロキサン(重合度30、分子量分散度1.19、片末端基エトキシ基)8.0g及びフェニル基を有するシリコーン(「シリコーンKF54」 信越化学株式会社製)7.0gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、本発明のシリコーン被覆顔料級二酸化チタ
ン1を得た。
Example 1 Production Example 1 of Silicone Coated Pigment Grade Titanium Dioxide
85 g of pigment grade titanium dioxide (average primary particle size 0.3 μm), α-triethoxypolymethylpolysiloxane (polymerization degree 30, molecular weight dispersity 1.19, one terminal ethoxy group) 8.0 g as reactive polyorganosiloxane A solution of 7.0 g of silicone having phenyl group (“silicone KF54” manufactured by Shin-Etsu Chemical Co., Ltd.) in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
This mixture was heat-treated at 150 ° C. for 8 hours to obtain a silicone- coated pigment grade titanium dioxide 1 of the present invention.
<実施例2〜6>シリコーン被覆無機有色顔料及び体質顔料の製造例1
実施例1における顔料級二酸化チタンを表1に示す無機有色顔料及び体質顔料に変更した以外は、実施例と同様の操作を行い、表1記載のシリコーン被覆無機有色顔料及び体質顔
料を得た。それぞれの粉体の平均一次粒子径は、黄色酸化鉄:0.3μm、ベンガラ0.3μm、黒色酸化鉄0.3μm、タルク5μm、セリサイト5μmであった。
<Examples 2 to 6> Production example 1 of silicone-coated inorganic colored pigment and extender pigment
A silicone-coated inorganic colored pigment and extender listed in Table 1 were obtained in the same manner as in Example 1 except that the pigment grade titanium dioxide in Example 1 was changed to the inorganic colored pigment and extender shown in Table 1. The average primary particle diameter of each powder was yellow iron oxide: 0.3 μm, bengara 0.3 μm, black iron oxide 0.3 μm, talc 5 μm, and sericite 5 μm.
<実施例7>シリコーン被覆顔料級二酸化チタンの製造例2
顔料級二酸化チタン85g(平均一次粒子径0.3μm)、反応性ポリオルガノシロキサンとしてα−モノヒドロキシポリシロキサン(重合度35、分子量分散度1.21、片末端基がモノシラノール基)7.5g及びフェニル基を有するシリコーン(「シリコーンKF56」信越化学株式会社製)7.5gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、本発明のシリコーン被覆顔料級二酸化チタ
ン2を得た。
<Example 7> Production example 2 of silicone-coated pigment-grade titanium dioxide
85 g of pigment grade titanium dioxide (average primary particle size 0.3 μm), α-monohydroxypolysiloxane as a reactive polyorganosiloxane (polymerization degree 35, molecular weight dispersion degree 1.21, one end group is a monosilanol group) 7.5 g In addition, a solution in which 7.5 g of silicone having a phenyl group (“silicone KF56” manufactured by Shin-Etsu Chemical Co., Ltd.) was dissolved in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
The mixture was heated for 8 hours treatment with 0.99 ° C., to obtain a silicone down the covering pigment-grade titanium dioxide 2 of the present invention.
<実施例8〜12>シリコーン被覆無機有色顔料及び体質顔料の製造例2
実施例7における顔料級二酸化チタンを表2に示す無機有色顔料及び体質顔料に変更した以外は、実施例と同様の操作を行い、表2記載のシリコーン被覆無機有色顔料及び体質顔料を得た。なお、それぞれの粉体の平均一次粒子径は、シリコーン被覆無機有色顔料及び体質顔料の製造例1と同様である。
<Examples 8 to 12> Production example 2 of silicone-coated inorganic colored pigment and extender pigment
Except having changed the pigment grade titanium dioxide in Example 7 into the inorganic colored pigment and extender pigment shown in Table 2, the same operation as in the Example was carried out to obtain the silicone-coated inorganic colored pigment and extender pigment described in Table 2. In addition, the average primary particle diameter of each powder is the same as that of Production Example 1 of the silicone-coated inorganic colored pigment and extender pigment.
<比較例1〜6>シリコーン被覆無機有色顔料及び体質顔料の製造例3
表3の顔料85g、反応性ポリオルガノシロキサンとしてα−トリエトキシポリメチルポリシロキサン(重合度30、分子量分散度1.19、片末端基エトキシ基)15.0gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、シリコーン被覆無機有色顔料及び体質顔料
を得た。なお、それぞれの粉体の平均一次粒子径は、シリコーン被覆無機有色顔料及び体質顔料の製造例1と同様である。
<Comparative Examples 1-6> Production Example 3 of Silicone-Coated Inorganic Colored Pigment and Extender Pigment
A solution obtained by dissolving 85 g of the pigment of Table 3 and 15.0 g of α-triethoxypolymethylpolysiloxane (polymerization degree 30, molecular weight dispersity 1.19, one-terminal ethoxy group) as reactive polyorganosiloxane in 50 ml of isopropyl alcohol. The mixture was stirred and mixed in a Henschel mixer.
This mixture was heat-treated at 150 ° C. for 8 hours to obtain a silicone-coated inorganic colored pigment and extender pigment. In addition, the average primary particle diameter of each powder is the same as that of Production Example 1 of the silicone-coated inorganic colored pigment and extender pigment.
<比較例7〜12>シリコーン被覆無機有色顔料及び体質顔料の製造例4
表4の顔料85g、フェニル基を有するシリコーン(「シリコーンKF54」信越化学株式会社製)15.0gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、シリコーン被覆無機有色顔料及び体質顔料
を得た。なお、それぞれの粉体の平均一次粒子径は、シリコーン被覆無機有色顔料及び体質顔料の製造例1と同様である。
<Comparative Examples 7-12> Production Example 4 of Silicone-Coated Inorganic Colored Pigment and Extender Pigment
A solution obtained by dissolving 85 g of the pigment of Table 4 and 15.0 g of a phenyl group-containing silicone (“Silicone KF54” manufactured by Shin-Etsu Chemical Co., Ltd.) in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
This mixture was heat-treated at 150 ° C. for 8 hours to obtain a silicone-coated inorganic colored pigment and extender pigment. In addition, the average primary particle diameter of each powder is the same as that of Production Example 1 of the silicone-coated inorganic colored pigment and extender pigment.
<製造例1>顔料ベースの調製
上記で調製したシリコーン被覆粉体を表5の割合で、ヘンシェルミキサー中で混合し、顔料ベース1〜4を調製した。顔料ベース1には上記シリコーン被覆粉体のうち、それぞれ1のみを使用した。以下顔料ベース2〜4も同様に調製した。なお表中の数字は重量部を表す。
<Manufacture example 1> Preparation of a pigment base The silicone coating powder prepared above was mixed in the ratio of Table 5 in the Henschel mixer, and the pigment bases 1-4 were prepared. For the pigment base 1, only one of the above silicone-coated powders was used. Hereinafter, pigment bases 2 to 4 were similarly prepared. The numbers in the table represent parts by weight.
<試験例1>シリコーン被覆顔料ベースの分散安定性
トリ−2エチルヘキサン酸グリセリルとジメチコン(20cs)を質量比7:3で混合した混合油剤26.85g、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル0.15g及び上記で調製したシリコーン被覆顔料ベース1〜4それぞれ3.0gを50mlガラス製スクリュー瓶にとり、10分間超音波処理を行い均一分散させた。この分散系を24時間放置し、シリコーン被覆顔料ベースの分散状態を肉眼にて観察した。結果を表6に示す。
<Test Example 1> Dispersion stability based on silicone-coated pigment 26.85 g of a mixed oil obtained by mixing glyceryl tri-2-ethylhexanoate and dimethicone (20 cs) at a mass ratio of 7: 3, 0.15 g of hexyl diethylaminohydroxybenzoylbenzoate and 3.0 g of each of the silicone-coated pigment bases 1 to 4 prepared above was placed in a 50 ml glass screw bottle and subjected to ultrasonic treatment for 10 minutes to be uniformly dispersed. This dispersion was allowed to stand for 24 hours, and the dispersion state of the silicone-coated pigment base was observed with the naked eye. The results are shown in Table 6.
<実施例13〜16、比較例13〜14>
表7に示す処方に従って、本発明の乳化形化粧料である、油中水形のサンスクリーン化粧料及び比較例の油中水形のサンスクリーン化粧料を調製した。すなわち、成分(イ)を75℃に加熱し、攪拌混合した。次に、成分(イ)に成分(ロ)を添加し、加熱を続けながら、ディスパーを用いて5000rpmで4分間攪拌し、成分(イ)に成分(ロ)を均一に分散させた。さらに、成分(ハ)を75℃に加熱、攪拌混合し、75℃を保ちながら、成分(イ)と成分(ロ)の混合物に成分(ハ)を攪拌下、添加し乳化を行った。その後、室温まで冷却し、油中水形のサンスクリーン化粧料を得た。なお表7中の数字は質量%を表す。
<Examples 13 to 16, Comparative Examples 13 to 14>
According to the formulation shown in Table 7, a water-in-oil sunscreen cosmetic and a comparative water-in-oil sunscreen cosmetic, which are emulsified cosmetics of the present invention, were prepared. That is, component (a) was heated to 75 ° C. and mixed with stirring. Next, the component (b) was added to the component (a), and the mixture was stirred for 4 minutes at 5000 rpm using a disper while continuing the heating, so that the component (b) was uniformly dispersed in the component (a). Furthermore, the component (c) was heated to 75 ° C. and mixed with stirring, and while maintaining the temperature at 75 ° C., the component (c) was added to the mixture of the component (a) and the component (b) with stirring to perform emulsification. Thereafter, it was cooled to room temperature to obtain a water-in-oil sunscreen cosmetic. The numbers in Table 7 represent mass%.
<試験例2>保存安定性の評価
実施例13〜16、比較例13〜14のサンスクリーン化粧料を50℃で3ヶ月保存した後、状態を肉眼で観察した。結果を表8に示す。
<Test Example 2> Evaluation of storage stability After the sunscreen cosmetics of Examples 13 to 16 and Comparative Examples 13 to 14 were stored at 50 ° C for 3 months, the state was observed with the naked eye. The results are shown in Table 8.
<試験例3>分散状態の評価
0.5ミルのドクターブレードを用いて、実施例13〜16、比較例13〜14のサンスクリーン化粧料の薄膜をスライドグラス上に作成した。この薄膜の560nmでの全透過率を積分球付きの分光光度計を用いて測定した。また、50℃で3ヶ月保存後にも同様の測定を行った。結果を表8に示す。透過率が小さいほど粉体の分散状態が良好であることを表す。
<Test Example 3> Evaluation of dispersion state Thin films of sunscreen cosmetics of Examples 13 to 16 and Comparative Examples 13 to 14 were formed on a slide glass using a 0.5 mil doctor blade. The total transmittance of this thin film at 560 nm was measured using a spectrophotometer with an integrating sphere. The same measurement was performed after storage at 50 ° C. for 3 months. The results are shown in Table 8. The smaller the transmittance, the better the dispersion state of the powder.
<試験例4>仕上がりの均一性の評価
熟練評価者5名により実施例13〜16、比較例13〜14のサンスクリーン化粧料を塗布した場合の使用感についての官能評価を行った。仕上がりの均一性を以下の評価基準に基づき評価した。評価では、5名の平均値を求めそのサンスクリーン化粧料の評点とした。また、50℃で3ヶ月保存した後にも同様の評価を行った。結果を表8に示す。
仕上がりの均一性が調製直後の比較例13と比較して:
かなり均一にまさる 5点
やや均一にまさる 4点
同等 3点
やや不均性に劣る 2点
かなり不均性に劣る 1点
<Test Example 4> Evaluation of finish uniformity Sensory evaluation was performed on the feeling of use when the sunscreen cosmetics of Examples 13 to 16 and Comparative Examples 13 to 14 were applied by five skilled evaluators. The uniformity of the finish was evaluated based on the following evaluation criteria. In the evaluation, the average value of 5 persons was obtained and used as the score of the sunscreen cosmetic. The same evaluation was performed after storage at 50 ° C. for 3 months. The results are shown in Table 8.
Compared to Comparative Example 13 where the finish uniformity was just after preparation:
5 points, which are considerably more uniform 4 points, which are slightly more uniform 4 points, equivalent 3 points, slightly inferiority 2 points, 1 point, which is considerably inferior 1
<試験例5>肌上での使用感の評価
熟練評価者5名により実施例13〜16、比較例13〜14のサンスクリーン化粧料を塗布した場合の使用感についての官能評価を行った。さっぱり感を以下の評価基準に基づき評価した。評価では、5名の平均値を求めそのサンスクリーン化粧料の評点とした。また、50℃で3ヶ月保存した後にも同様の評価を行った。結果を表8に示す。
さっぱり感が調製直後の比較例13と比較して:
かなりある 5点
ややある 4点
同等 3点
ややない 2点
かなりない 1点
<Test Example 5> Evaluation of feeling on the skin Sensory evaluation was performed on the feeling when the sunscreen cosmetics of Examples 13 to 16 and Comparative Examples 13 to 14 were applied by five skilled evaluators. The refreshing feeling was evaluated based on the following evaluation criteria. In the evaluation, the average value of 5 persons was obtained and used as the score of the sunscreen cosmetic. The same evaluation was performed after storage at 50 ° C. for 3 months. The results are shown in Table 8.
Compared to Comparative Example 13 immediately after preparation, the refreshing feeling:
There are quite 5 points Somewhat 4 points Equivalent 3 points Somewhat not 2 Points Not quite 1 point
表8より明らかなように本発明の皮膚外用剤は粉体の分散安定性が良好であり、その結果として、優れた使用感とメークアップ効果を有する。 As is apparent from Table 8, the external preparation for skin of the present invention has good dispersion stability of the powder, and as a result, has excellent use feeling and make-up effect.
<実施例17〜20、比較例15〜16>
表9に示す処方に従って、本発明の乳化形化粧料である、水中油形のサンスクリーン化粧料及び比較例の水中油形のサンスクリーン化粧料を調製した。すなわち、成分(イ)を75℃に加熱し、攪拌混合した。次に、成分(イ)に成分(ロ)を添加し、加熱を続けながら、ディスパーを用いて5000rpmで4分間攪拌し、成分(イ)に成分(ロ)を均一に分散させた。さらに、成分(ハ)を75℃に加熱、攪拌混合し、75℃を保ちながら、成分(イ)と成分(ロ)の混合物に成分(ハ)を攪拌下、添加し乳化を行った。その後、室温まで冷却し、水中油形のサンスクリーン化粧料を得た。なお表9中の数字は質量%を表す。また、実施例17〜20及び比較例15〜16のサンスクリーン化粧料について、試験例2〜5と同様に、保存安定性、分散状態、仕上がりの均一性、肌上での使用感を評価した。結果を表10に示す。
<Examples 17-20, Comparative Examples 15-16>
According to the formulation shown in Table 9, an oil-in-water sunscreen cosmetic and a comparative oil-in-water sunscreen cosmetic, which are emulsified cosmetics of the present invention, were prepared. That is, component (a) was heated to 75 ° C. and mixed with stirring. Next, the component (b) was added to the component (a), and the mixture was stirred for 4 minutes at 5000 rpm using a disper while continuing the heating, so that the component (b) was uniformly dispersed in the component (a). Furthermore, the component (c) was heated to 75 ° C. and mixed with stirring, and while maintaining the temperature at 75 ° C., the component (c) was added to the mixture of the component (a) and the component (b) with stirring to perform emulsification. Thereafter, the mixture was cooled to room temperature to obtain an oil-in-water sunscreen cosmetic. The numbers in Table 9 represent mass%. In addition, the sunscreen cosmetics of Examples 17 to 20 and Comparative Examples 15 to 16 were evaluated in the same manner as in Test Examples 2 to 5, for storage stability, dispersion state, finish uniformity, and feeling on the skin. . The results are shown in Table 10.
表10から明らかなように水中油剤形においても本発明の皮膚外用剤が粉体の分散安定
性に優れ、その結果として、優れた使用感とメークアップ効果を有することが証明された。
As is apparent from Table 10, it was proved that the skin external preparation of the present invention was excellent in dispersion stability of the powder even in the oil-in-water dosage form, and as a result, had excellent usability and make-up effect.
本発明は日焼け止め化粧料やメークアップ化粧料等に活用できる。 The present invention can be used for sunscreen cosmetics, makeup cosmetics, and the like.
Claims (7)
(a)重合度が25以上100以下、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値が1以上1.3以下であって、少なくとも一方の分子鎖末端にアルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される少なくとも1種を有する直鎖状の反応性オルガノポリシロキサン
(b)少なくとも1つのフェニル基を有するオルガノポリシロキサン A skin external preparation containing a powder coated with the following (a) and (b) having an average primary particle diameter of 100 nm or more and an ultraviolet absorber.
(A) The degree of polymerization is 25 or more and 100 or less, and the ratio Mw / Mn of the weight average molecular weight Mw and the number average molecular weight Mn is 1 or more and 1.3 or less. , A linear reactive organopolysiloxane having at least one selected from the group consisting of a halogen atom, an amino group and an imino group (b) an organopolysiloxane having at least one phenyl group
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013178815A JP6383141B2 (en) | 2013-08-30 | 2013-08-30 | Surface-treated powder and skin external preparation containing the surface-treated powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013178815A JP6383141B2 (en) | 2013-08-30 | 2013-08-30 | Surface-treated powder and skin external preparation containing the surface-treated powder |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015048308A JP2015048308A (en) | 2015-03-16 |
JP2015048308A5 JP2015048308A5 (en) | 2016-09-23 |
JP6383141B2 true JP6383141B2 (en) | 2018-08-29 |
Family
ID=52698607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013178815A Active JP6383141B2 (en) | 2013-08-30 | 2013-08-30 | Surface-treated powder and skin external preparation containing the surface-treated powder |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6383141B2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3567335B2 (en) * | 1993-12-28 | 2004-09-22 | 三好化成株式会社 | Organosilicon compound-treated pigment or extender, method for producing the same and cosmetics |
JP3822782B2 (en) * | 2000-07-06 | 2006-09-20 | 三好化成株式会社 | Sebum-adsorbing powder and use thereof |
JP2003212711A (en) * | 2002-01-24 | 2003-07-30 | Shiseido Co Ltd | Make-up cosmetic |
JP2004315467A (en) * | 2003-04-18 | 2004-11-11 | Miyoshi Kasei Inc | Sebum adsorbing powder and use thereof |
-
2013
- 2013-08-30 JP JP2013178815A patent/JP6383141B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015048308A (en) | 2015-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4560122B2 (en) | Titanium oxide dispersion and cosmetics containing the same | |
EP2915524A1 (en) | Sunscreen cosmetic | |
JP6180136B2 (en) | Water-in-oil emulsified cosmetic | |
WO2007060823A1 (en) | External preparation for skin | |
JP5808083B2 (en) | Sunscreen cosmetics | |
JP2010195773A (en) | Water-in-oil type emulsified sunburn care cosmetic | |
JP2014097937A (en) | Water-in-silicone oil macroemulsion cosmetic composition | |
JPWO2017057676A1 (en) | Sunscreen cosmetics | |
TW201827036A (en) | Oil-in-water type emulsion cosmetic | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
KR102715221B1 (en) | Make-up cosmetic composition comprising scoria powder | |
US8420066B2 (en) | O/W emulsion cosmetic composition | |
JP2007508281A (en) | Water-in-silicone emulsions for use as sunscreen products | |
JP6674816B2 (en) | Water-in-oil emulsion composition | |
JP6178089B2 (en) | Dullness improvement cosmetic | |
JP2013112615A (en) | Emulsion type cosmetic | |
JP6366241B2 (en) | Fine particle metal oxide and external preparation for skin containing the fine particle metal oxide | |
JP6383141B2 (en) | Surface-treated powder and skin external preparation containing the surface-treated powder | |
JP6831737B2 (en) | Underwater oil type cosmetics | |
JP2015048305A (en) | Surface treated powder and external preparation for skin containing surface treated powder | |
JP2016041665A (en) | Sunscreen skin external preparation | |
JP2015030723A (en) | Emulsifier type sunscreen cosmetic | |
TWI745304B (en) | Cosmetic composition for blocking ultraviolet | |
JP2015048304A (en) | Particulate metal oxide, and external preparation for skin containing particulate metal oxide | |
JP2015048311A (en) | Emulsified cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160802 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160802 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170517 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170627 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180501 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20180510 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180612 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180620 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180710 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180803 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6383141 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |